Pharmaceutical Form
Unit-dose paste with gauze backing for topical application.

Therapeutic Indications
For the treatment of chronic exuding wounds, eg leg ulcers. The underlying disease must also be treated.
When applied to wounds, Iodoflex reduces the bacterial count. In chronic leg ulcers it accelerates healing and reduces pain.
For topical application.

Posology And Method Of Administration
In adults and the elderly, Iodoflex is applied to the wound surface and then covered with a dry gauze dressing. The frequency of change depends on the exudation from the wound. Changes should be made when the Iodoflex has become saturated with wound exudate, indicated by loss of colour, usually two to three times a week. If the wound is exuding heavily, daily changes may be needed.
Each time the unit dose paste is changed and at the end of the treatment the remaining Iodoflex should be gently removed from the wound surface with a stream of water or saline.

A single application should not exceed 50g. The total amount of Iodoflex used in one week should not exceed 150g.
The duration of treatment should not exceed three months in any single course of treatment.
There is no experience in children, therefore Iodoflex is not recommended.

Contraindications
Iodoflex is contraindicated in :
• patients with known or suspected iodine sensitivity
• Hashimoto's thyroiditis
• non-toxic nodular goitre
• children

Iodoflex should not be used :
• by pregnant or lactating women

Qualitative and Quantitative Composition
1g unit-dose paste contains :
Cadexomer iodine 600mg, equivalent to :
Iodine 9mg Ph. Eur.
Cadexomer 591mg Ph. Eur.

No info